Back to 
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
XERS
Showing 0 of 2 quarters
Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in XERIS PHARMACEUTICALS INC
No. Arrowstreet Capital exited its XERS (Xeris Pharmaceuticals) position in Q3 2020. Its Q2 2020 13F listed 42,000 shares worth $112,000. Arrowstreet Capital first reported XERS in Q2 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.